Genmab

Denmark
Copenhagen, Capital Region, Denmark, 1260

Company profile

Genmab company profile

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.

Business identity

Contact email
[email protected]
Phone number
+ 45 7020 2728
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$100M-$1B
Founded
1999-01-01, Year

Headquarters

Postal code
1260
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$204.3M
Last funding
Post IPO Debt / $6B / 2025-11-18
Last equity funding
Post IPO Equity / $134M
Investors
7
Lead investors
4
Founders
1
Articles
685
Exited on
2000-10-01

Founders and investors

Founders

Don Drakeman

Lead investors

BankInvest Biomedical VentureGlaxoSmithKlineIndex VenturesMorgan Stanley Senior Funding

Investors

Apax Partners DevelopmentBankInvest Biomedical VentureGlaxoSmithKlineIndex VenturesMorgan Stanley Senior Funding